Robert F. Kennedy Jr., one of President-elect Donald J. Trump’s advisers on health, is taking aim at the agency’s oversight ...

Received a "Study May Proceed” letter from the U.S. Food and Drug Administration (FDA ... 3 trial for the first-line ...

Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical” or "the Company”, "we”, or "our”), a commercial-stage ...

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

6. Cell therapy for melanoma The U.S. Food and Drug Administration (FDA) approved the first cellular therapy for aggressive ...

GNSC-001 is an investigational, adeno-associated virus gene therapy expressing an optimized form of IL-1Ra. The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for ...

In the wake of the biggest American political comeback in more than 100 years, stakeholders in the health industry are asking themselves: What ...

Bones are full of collagen, but as you get older, the protein starts to deteriorate -- and so does bone health -- leading to ...

When you’re feeling under the weather, you likely grab your go-to cough and cold medicine. But are all the ingredients ...

On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...